AXSM
Axsome Therapeutics, Inc. · Healthcare · Biotechnology
Input momentum (manajer yang sebanding): keluasan pemegang 0.0% · aliran saham +8.7% · posisi baru bersih -5.3% — formula
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q3 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 131 | +8 | 27.61M | $6.75B | +16 | −7 |
| Q1 2026 | 125 | +4 | 27.78M | $4.69B | +9 | −6 |
| Q4 2025 | 120 | +1 | 28.15M | $5.13B | +2 | — |
| Q3 2025 | 19 | 0 | 15.93M | $1.93B | +1 | −2 |
| Q2 2025 | 17 | -1 | 13.98M | $1.46B | — | −1 |
| Q1 2025 | 15 | +3 | 4.41M | $513.88M | +3 | — |
| Q4 2024 | 12 | +1 | 3.90M | $329.80M | +1 | — |
| Q3 2024 | 10 | 0 | 3.50M | $314.34M | — | — |
| Q2 2024 | 10 | — | 4.77M | $384.18M | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasif) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasif) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasif) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasif) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | The Vanguard Group ✦ (pasif) | 4.18M | +6.0% | $507.74M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 12 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 13 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 14 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 18 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 21 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 22 | BlackRock ✦ (pasif) | 3.79M | -1.1% | $460.41M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 23 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 24 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 25 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 26 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 27 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 28 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Wellington Management ✦ | 1.33M | +84.1% | $162.08M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | T. Rowe Price ✦ | 1.04M | +69.3% | $126.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 31 | T. Rowe Price ✦ | 1.04M | +69.3% | $126.00M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 32 | Geode Capital Management ✦ (pasif) | 997.70K | +0.8% | $121.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 33 | Geode Capital Management ✦ (pasif) | 997.70K | +0.8% | $121.19M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 34 | State Street Global Advisors ✦ (pasif) | 942.96K | -1.6% | $114.52M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 35 | Fidelity (FMR) ✦ | 927.88K | -5.0% | $112.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 927.88K | -5.0% | $112.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 37 | Fidelity (FMR) ✦ | 927.88K | -5.0% | $112.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 38 | Fidelity (FMR) ✦ | 927.88K | -5.0% | $112.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 39 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 40 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 41 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 42 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 43 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 44 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 45 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 46 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 47 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 48 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 49 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 50 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 51 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 52 | JPMorgan Chase ✦ | 501.03K | — | $60.85M | 0.0% | n/c | 1 | SEC ↗ |
| 53 | Adage Capital Partners ✦ | 445.00K | -0.5% | $54.05M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 54 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 55 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 56 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 57 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 58 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 59 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 60 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 61 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 62 | Morgan Stanley ✦ | 409.58K | — | $49.74M | 0.0% | n/c | 1 | SEC ↗ |
| 63 | Marshall Wace ✦ | 378.02K | +566.5% | $45.91M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 64 | Marshall Wace ✦ | 378.02K | +566.5% | $45.91M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 65 | Marshall Wace ✦ | 378.02K | +566.5% | $45.91M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 66 | D. E. Shaw & Co. ✦ | 296.29K | +47.6% | $35.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 67 | D. E. Shaw & Co. ✦ | 296.29K | +47.6% | $35.98M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 68 | Goldman Sachs Group ✦ | 224.14K | — | $27.22M | 0.0% | n/c | 1 | SEC ↗ |
| 69 | Goldman Sachs Group ✦ | 224.14K | — | $27.22M | 0.0% | n/c | 1 | SEC ↗ |
| 70 | Goldman Sachs Group ✦ | 224.14K | — | $27.22M | 0.0% | n/c | 1 | SEC ↗ |
| 71 | Citadel Advisors ✦ | 158.41K | +1063.2% | $19.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 72 | Citadel Advisors ✦ | 158.41K | +1063.2% | $19.24M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 73 | Renaissance Technologies ✦ | 150.00K | +8.2% | $18.22M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 74 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 75 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 76 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 77 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 78 | AQR Capital Management ✦ | 118.66K | -7.2% | $14.41M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 79 | Point72 Asset Management ✦ | 18.71K | -94.7% | $2.27M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 80 | Two Sigma Investments ✦ | 8.21K | Baru | $996,740 | 0.0% | New | 1 | SEC ↗ |
| 81 | Millennium Management ✦ | 5.74K | -81.2% | $697,244 | 0.0% | ▼ Trim | 6 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Two Sigma Investments | $996,740 | 0.0% |
Telah keluar
| Norges Bank | $48.89M | adalah 0.0% |
| Bridgewater Associates | $11.20M | adalah 0.0% |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 1 pemegang, 11.40K saham, $1,926 dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.